<< Back To Home

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: A modeling study

Monday, 27th of May 2019 Print

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: A modeling study

From The Lancet Infectious Diseases

https://www.thelancet.com/action/showPdf?pii=S1473-3099%2818%2930804-1

24760492